Institutional investors purchased a net $139.0 million shares of ABBV during the quarter ended September 2014 and now own 80.59% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
REGIONS INVESTMENT MANAGEMENT, I... Bought 224.8 Thousand shares of AbbVie
HANDELSBANKEN FONDER AB Bought 145.9 Thousand shares of AbbVie
RAIL-SPLITTER CAPITAL MANAGEMENT... Bought 140.7 Thousand shares of AbbVie